Unicharm (8113) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Net sales for the nine months ended September 30, 2024, reached 722.1 billion JPY (YOY +5.0%), and core operating income was 103.6 billion JPY (YOY +11.7%), driven by value-shifting, cost reductions, and strong overseas and Japan performance.
Sales and core operating income hit all-time highs for the seventh consecutive year, with stable earnings despite increased investments and higher logistics and personnel costs.
Profit before tax decreased 0.3% YOY to 100.8 billion JPY, and profit attributable to owners of parent declined 2.4% to 59.6 billion JPY.
Overseas markets showed recovery in key regions, while Japan maintained strong sales growth due to effective cost pass-through and value-added product strategies.
Financial highlights
Net sales: 722.1 billion JPY (YOY +5.0%), core operating income: 103.6 billion JPY (YOY +11.7%), EBITDA: 135.6 billion JPY (YOY +2.1%).
Gross profit increased to 284.6 billion JPY, and gross profit margin improved due to value-shifting and cost reductions.
Core operating income margin: 14.3%–14.4% (YOY +0.8pt).
Base/basic EPS: 101.23 JPY (YOY -1.7%).
Total assets as of September 30, 2024: 1,164.5 billion JPY, up 2.7% from year-end 2023.
Outlook and guidance
Full-year 2024 forecast maintained: net sales 1,006 billion JPY (YOY +6.8%), core operating income 144 billion JPY (YOY +12.5%), profit attributable to owners of parent 90 billion JPY (YOY +4.6%), and basic EPS 153.49 JPY.
Annual dividend forecast raised to 44 JPY per share, marking 23 consecutive years of increases.
Aiming to achieve annual targets by boosting sales and profit in Q4, with continued strategic investments and focus on value-shifting.
Expecting strong performance in Japan, India, Middle East, and North America, while recovery in Southeast Asia and China remains delayed.
Latest events from Unicharm
- Profits fell in FY2025, but FY2026 forecasts strong recovery and higher dividends.8113
Q4 202512 Feb 2026 - Sales and core profit declined, but profit attributable to owners rose 2.0% YoY.8113
Q3 20257 Nov 2025 - Sales and profits fell, but resilient regions and cost controls support a recovery outlook.8113
Q2 20255 Aug 2025 - Record sales and profit growth continue, with strong overseas and segment performance.8113
Q2 202413 Jun 2025 - Net profit jumped in Q1 FY2025 despite lower sales, aided by insurance proceeds.8113
Q1 20256 Jun 2025 - Record sales and profit growth, with a stock split and strong FY2025 outlook.8113
Q4 20245 Jun 2025